bixt: the income statement

MyFinsight

BIOXYTRAN, INC (BIXT)

For the quarter ending 2025-06-30, BIXT made $307,402 in revenue. $35,437 in net income. Net profit margin of 11.53%.

Unit: Dollar

	2025-06-30
Provision for income taxes	-
Research and development	102,500
General and administrative	99,531
General and administrative affiliates	22,048
Total operating expenses	224,079
Loss from operations	-224,079
Interest expense	30,112
Change in fair value (fv) of derivative	307,402
Amortization of ip	2,509
Interest expense affiliates	15,265
Gain/loss of issuance	-
Debt discount amortization and issuance of warrants	-
Total other income (expenses)	259,516
Net loss before provision for income taxes	35,437
Net loss	35,437
Net loss attributable to the non-controlling interest	-
Net loss attributable to bioxytran	35,437

Earning per common share, basic	-
Earning per common share, diluted	-
Weighted average number of common shares out-standing, basic	88,839,723
Weighted average number of common shares out-standing, diluted	88,839,723

Unit: Dollar